Biofrontera Inc. (NASDAQ:BFRI) Sees Significant Decrease in Short Interest

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 292,400 shares, a drop of 44.9% from the December 31st total of 530,600 shares. Based on an average trading volume of 3,010,000 shares, the short-interest ratio is currently 0.1 days. Approximately 4.7% of the shares of the stock are sold short.

Biofrontera Stock Up 1.9 %

Shares of BFRI stock opened at $1.06 on Wednesday. The stock has a 50-day simple moving average of $1.04 and a 200 day simple moving average of $1.06. Biofrontera has a fifty-two week low of $0.61 and a fifty-two week high of $2.43.

Analyst Ratings Changes

Separately, Benchmark reissued a “buy” rating and set a $7.00 target price on shares of Biofrontera in a report on Friday, November 15th.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.